The prognostic impact of uric acid in patients with severely decompensated acute heart failure

Journal of Cardiology

Volumn 68, Issue 5, 2016, Pages 384-391

  Okazaki, Hirotake ^a   Shirakabe, Akihiro ^a   Kobayashi, Nobuaki ^a   Hata, Noritake ^a   Shinada, Takuro ^a   Matsushita, Masato ^a   Yamamoto, Yoshiya ^a   Shibuya, Junsuke ^a   Shiomura, Reiko ^a   Nishigoori, Suguru ^a   Asai, Kuniya ^b   Shimizu, Wataru ^b  

^a NIPPON MEDICAL SCHOOL CHIBA HOKUSOH HOSPITAL   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Acute heart failure syndrome; Loop diuretics; Renal failure; Uric acid

Indexed keywords

BICARBONATE; BRAIN NATRIURETIC PEPTIDE; CREATININE; HEMOGLOBIN; LOOP DIURETIC AGENT; POTASSIUM; UREA; URIC ACID;

ACUTE HEART FAILURE; AGED; ARTICLE; BICARBONATE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CARBON DIOXIDE TENSION; CARDIOVASCULAR MORTALITY; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HYPERURICEMIA; INTENSIVE CARE UNIT; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; POTASSIUM BLOOD LEVEL; PROTEIN BLOOD LEVEL; UREA BLOOD LEVEL; URIC ACID BLOOD LEVEL; VERY ELDERLY; ACUTE DISEASE; BLOOD; CHRONIC KIDNEY FAILURE; EPIDEMIOLOGY; HEART FAILURE; JAPAN; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PROGNOSIS;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; FEMALE; HEART FAILURE; HUMANS; HYPERURICEMIA; JAPAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; URIC ACID;

EID: 84973558363     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2016.04.013     Document Type: Article

References (39)

1. [1] Grayson, P.C., Kim, S.Y., LaValley, M., Choi, H.K., Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res 63 (2011), 102–110.
2. [2] Billiet, L., Doaty, S., Katz, J.D., Velasquez, M.T., Review of hyperuricemia as new marker for metabolic syndrome. ISRN Rheumatol, 2014, 2014, 852954.
3. [3] Obermayr, R.P., Temml, C., Gutjahr, G., Knechtelsdorfer, M., Oberbauer, R., Klauser-Braun, R., Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol 19 (2008), 2407–2413.
4. [4] Kim, S.Y., Guevara, J.P., Kim, K.M., Choi, H.K., Heitjan, D.F., Albert, D.A., Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum 61 (2009), 885–892.
5. [5] Zhao, G., Huang, L., Song, M., Song, Y., Baseline serum uric acid level as a predictor of cardiovascular disease related mortality and all-cause mortality: a meta-analysis of prospective studies. Atherosclerosis 231 (2013), 61–68.
6. [6] Huang, H., Huang, B., Li, Y., Huang, Y., Li, J., Yao, H., Jing, X., Chen, J., Wang, J., Uric acid and risk of heart failure: a systematic review and meta-analysis. Eur J Heart Fail 16 (2014), 15–24.
7. [7] Tamariz, L., Harzand, A., Palacio, A., Verma, S., Jones, J., Hare, J., Uric acid as a predictor of all-cause mortality in heart failure: a meta-analysis. Congest Heart Fail 17 (2011), 25–30.
8. [8] Kim, H., Shin, H.W., Son, J., Yoon, H.J., Park, H.S., Cho, Y.K., Han, C.D., Nam, C.W., Hur, S.H., Kim, Y.N., Kim, K.B., Uric acid as prognostic marker in advanced nonischemic dilated cardiomyopathy: comparison with N-terminal pro B-type natriuretic peptide level. Congest Heart Fail 16 (2010), 153–158.
9. [9] Levy, W.C., Mozaffarian, D., Linker, D.T., Sutradhar, S.C., Anker, S.D., Cropp, A.B., Anand, I., Maggioni, A., Burton, P., Sullivan, M.D., Pitt, B., Poole-Wilson, P.A., Mann, D.L., Packer, M., The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 113 (2006), 1424–1433.
10. [10] Manzano, L., Babalis, D., Roughton, M., Shibata, M., Anker, S.D., Ghio, S., van Veldhuisen, D.J., Cohen-Solal, A., Coats, A.J., Poole-Wilson, P.P., Flather, M.D., SENIORS Investigators. Predictors of clinical outcomes in elderly patients with heart failure. Eur J Heart Fail 13 (2011), 528–536.
11. [11] Shimizu, T., Yoshihisa, A., Kanno, Y., Takiguchi, M., Sato, A., Miura, S., Nakamura, Y., Yamauchi, H., Owada, T., Abe, S., Sato, T., Suzuki, S., Oikawa, M., Yamaki, T., Sugimoto, K., et al. Relationship of hyperuricemia with mortality in heart failure patients with preserved ejection fraction. Am J Physiol Heart Circ Physiol 309 (2015), H1123–H1129.
12. [12] Hamaguchi, S., Furumoto, T., Tsuchihashi-Makaya, M., Goto, K., Goto, D., Yokota, T., Kinugawa, S., Yokoshiki, H., Takeshita, A., Tsutsui, H., JCARE-CARD Investigators. Hyperuricemia predicts adverse outcomes in patients with heart failure. Int J Cardiol 151 (2011), 143–147.
13. [13] Huang, W.M., Hsu, P.F., Cheng, H.M., Lu, D.Y., Cheng, Y.L., Guo, C.Y., Sung, S.H., Yu, W.C., Chen, C.H., Determinants and prognostic impact of hyperuricemia in hospitalization for acute heart failure. Circ J 80 (2016), 404–410.
14. [14] Alimonda, A.L., Núñez, J., Núñez, E., Husser, O., Sanchis, J., Bodí, V., Miñana, G., Robles, R., Mainar, L., Merlos, P., Darmofal, H., Llácer, A., Hyperuricemia in acute heart failure. More than a simple spectator?. Eur J Intern Med 20 (2009), 74–79.
15. [15] Gheorghiade, M., Zannad, F., Sopko, G., Klein, L., Piña, I.L., Konstam, M.A., Massie, B.M., Roland, E., Targum, S., Collins, S.P., Filippatos, G., Tavazzi, L., International Working Group on Acute Heart Failure Syndromes. Acute heart failure syndromes: current state and framework for future research. Circulation 112 (2005), 3958–3968.
16. [16] Nieminen, M.S., Harjola, V.P., Definition and epidemiology of acute heart failure syndromes. Am J Cardiol 96 (2005), 5g–10g.
17. [17] McMurray, J.J., Adamopoulos, S., Anker, S.D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., Gomez-Sanchez, M.A., Jaarsma, T., Køber, L., Lip, G.Y., Maggioni, A.P., Parkhomenko, A., et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33 (2012), 1787–1847.
18. [18] Yamanaka, H., Metabolism, T.G., Essence of the revised guideline for the management of hyperuricemia and gout. Japan Med Assoc J 55 (2012), 324–329.
19. [19] Mebazaa, A., Gheorghiade, M., Piña, I.L., Harjola, V.P., Hollenberg, S.M., Follath, F., Rhodes, A., Plaisance, P., Roland, E., Nieminen, M., Komajda, M., Parkhomenko, A., Masip, J., Zannad, F., Filippatos, G., Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes. Crit Care Med 36 (2008), S129–S139.
20. [20] Sato, N., Kajimoto, K., Asai, K., Mizuno, M., Minami, Y., Nagashima, M., Murai, K., Muanakata, R., Yumino, D., Meguro, T., Kawana, M., Nejima, J., Satoh, T., Mizuno, K., Tanaka, K., et al. Acute decompensated heart failure syndromes (ATTEND) registry. A prospective observational multicenter cohort study: rationale, design, and preliminary data. Am Heart J, 159, 2010 949–55.e1.
21. [21] Tsutsui, H., Tsuchihashi-Makaya, M., Kinugawa, S., Goto, D., Takeshita, A., Investigators, J.-C., Clinical characteristics and outcome of hospitalized patients with heart failure in Japan. Circ J 70 (2006), 1617–1623.
22. [22] Shiba, N., Shimokawa, H., Chronic heart failure in Japan: implications of the CHART studies. Vasc Health Risk Manag 4 (2008), 103–113.
23. [23] Hirotsu, C., Tufik, S., Guindalini, C., Mazzotti, D.R., Bittencourt, L.R., Andersen, M.L., Association between uric acid levels and obstructive sleep apnea syndrome in a large epidemiological sample. PLoS ONE, 8, 2013, e66891.
24. [24] Ozanturk, E., Ucar, Z.Z., Varol, Y., Koca, H., Demir, A.U., Kalenci, D., Halilcolar, H., Ozacar, R., Urinary uric acid excretion as an indicator of severe hypoxia and mortality in patients with obstructive sleep apnea and chronic obstructive pulmonary disease. Rev Port Pneumol (2006) 22:January–February (1) (2016), 18–26.
25. [25] Málek, F., Ošťádal, P., Pařenica, J., Jarkovský, J., Vítovec, J., Widimský, P., Linhart, A., Fedorco, M., Coufal, Z., Miklík, R., Krűger, A., Vondraková, D., Špinar, J., Uric acid, allopurinol therapy, and mortality in patients with acute heart failure – results of the Acute HEart FAilure Database registry. J Crit Care 27 (2012), 737.e11–737.e24.
26. [26] Kawai, T., Ohishi, M., Takeya, Y., Onishi, M., Ito, N., Yamamoto, K., Kamide, K., Rakugi, H., Serum uric acid is an independent risk factor for cardiovascular disease and mortality in hypertensive patients. Hypertens Res 35 (2012), 1087–1092.
27. [27] Ishizaka, N., Ishizaka, Y., Toda, E., Nagai, R., Yamakado, M., Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol 25 (2005), 1038–1044.
28. [28] Faller, J., Fox, I.H., Ethanol-induced hyperuricemia: evidence for increased urate production by activation of adenine nucleotide turnover. N Engl J Med 307 (1982), 1598–1602.
29. [29] Seki, S., Oki, Y., Tsunoda, S., Takemoto, T., Koyama, T., Yoshimura, M., Impact of alcohol intake on the relationships of uric acid with blood pressure and cardiac hypertrophy in essential hypertension. J Cardiol(December), 2015, 10.1016/j.jjcc.2015.11.006.
30. [30] Luna-Luna, M., Medina-Urrutia, A., Vargas-Alarcon, G., Coss-Rovirosa, F., Vargas-Barron, J., Perez-Mendez, O., Adipose tissue in metabolic syndrome: onset and progression of atherosclerosis. Arch Med Res 46 (2015), 392–407.
31. [31] Lv, Q., Meng, X.F., He, F.F., Chen, S., Su, H., Xiong, J., Gao, P., Tian, X.J., Liu, J.S., Zhu, Z.H., Huang, K., Zhang, C., High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies. PLoS ONE, 8, 2013, e56864.
32. [32] Peng, T.C., Wang, C.C., Kao, T.W., Chan, J.Y., Yang, Y.H., Chang, Y.W., Chen, W.L., Relationship between hyperuricemia and lipid profiles in US adults. Biomed Res Int, 2015, 2015, 127596.
33. [33] Okazaki, H., Shirakabe, A., Hata, N., Yamamoto, M., Kobayashi, N., Shinada, T., Tomita, K., Tsurumi, M., Matsushita, M., Yamamoto, Y., Yokoyama, S., Asai, K., Shimizu, W., New scoring system (APACHE-HF) for predicting adverse outcomes in patients with acute heart failure: evaluation of the APACHE II and Modified APACHE II scoring systems. J Cardiol 64 (2014), 441–449.
34. [34] Kawase, T., Toyofuku, M., Higashihara, T., Okubo, Y., Takahashi, L., Kagawa, Y., Yamane, K., Mito, S., Tamekiyo, H., Otsuka, M., Okimoto, T., Muraoka, Y., Masaoka, Y., Shiode, N., Hayashi, Y., Validation of lactate level as a predictor of early mortality in acute decompensated heart failure patients who entered intensive care unit. J Cardiol 65 (2015), 164–170.
35. [35] Hasselblad, V., Gattis Stough, W., Shah, M.R., Lokhnygina, Y., O'Connor, C.M., Califf, R.M., Adams, K.F. Jr., Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur J Heart Fail 9 (2007), 1064–1069.
36. [36] Hamaguchi, S., Kinugawa, S., Tsuchihashi-Makaya, M., Goto, D., Yamada, S., Yokoshiki, H., Takeshita, A., Tsutsui, H., JCARE-CARD Investigators. Loop diuretic use at discharge is associated with adverse outcomes in hospitalized patients with heart failure: a report from the Japanese cardiac registry of heart failure in cardiology (JCARE-CARD). Circ J 76 (2012), 1920–1927.
37. [37] Hamaguchi, S., Tsuchihashi-Makaya, M., Kinugawa, S., Yokota, T., Ide, T., Takeshita, A., Tsutsui, H., JCARE-CARD Investigators. Chronic kidney disease as an independent risk for long-term adverse outcomes in patients hospitalized with heart failure in Japan. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). Circ J 73 (2009), 1442–1447.
38. [38] Shiba, N., Shimokawa, H., Chronic kidney disease and heart failure – bidirectional close link and common therapeutic goal. J Cardiol 57 (2011), 8–17.
39. [39] Sato, N., Kajimoto, K., Keida, T., Mizuno, M., Minami, Y., Yumino, D., Asai, K., Murai, K., Muanakata, R., Aokage, T., Sakata, Y., Mizuno, K., Takano, T., TEND Investigators. Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND Registry). Circ J 77 (2013), 944–951.